Executive Committee

Ian Taylor, Ph.D.

President, R&D

Dr. Ian Taylor serves as the President, R&D at Arvinas. Prior to joining Arvinas, Dr. Taylor served a decade at Pfizer Oncology as an Early Development Team Leader. During this time, Dr. Taylor was responsible for leading a cross-functional drug development team that conducted Phase 1 and Phase 2 clinical trials for multiple assets in several cancer indications. He also served as Senior Director of Translational Oncology, where he was responsible for directing translational science activities, which included designing and executing translational research plans and leading companion diagnostic partnerships for programs in both preclinical and clinical (Phase 1 -3) stages.

Dr. Taylor also worked at Bayer Healthcare Pharmaceuticals, holding positions of increasing responsibility, including Vice President of Cancer Biology, where he led biology aspects of small molecule drug discovery of cancer therapeutics in the mechanistic areas of signal transduction, cell cycle regulation, angiogenesis and apoptosis.

During his tenure, the Cancer Biology group delivered numerous molecules to the Development organization. He also started and led the Biomarker group, which contributed to the development of sorafenib.

Dr. Taylor earned his B.A. from Bowdoin College and his Ph.D. in Molecular Biology and Genetics from Harvard University. He also completed his postdoctoral training in the laboratory of Dr. Harold Varmus at the University of California, San Francisco and the National Institutes of Health (NIH).